Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

NuuVim review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

NuuVim advertises semaglutide from $79 a month and tirzepatide from $133 for new GLP-1 users. Confirm your dose and renewal amount before relying on either starting figure.

From $79/mo for new GLP-1 users

See plans at NuuVim
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

NuuVim at a glance

Semaglutide
From $79/mo for new GLP-1 users
Tirzepatide
From $133/mo for new GLP-1 users
Coverage
Not verified by observation
Brand-name
Yes

How we scored NuuVim

Every factor comes from NuuVim's own published pricing, disclosures and oversight, and the six combine into the 37/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance20/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit25/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs50/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost55/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support42/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness35/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

NuuVim advertises semaglutide from $79 a month and tirzepatide from $133 for new GLP-1 users. Confirm your dose and renewal amount before relying on either starting figure.

Before you sign up

What NuuVim's public site and signup page show before you hand over any details.

Worth knowing

  • The intake runs on Bask Health rather than on the provider's own software
  • A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number

Pricing

MedicationPricePlan
Compounded semaglutide$79New-user injectable floorNew GLP-1 user starting amount; renewal and dose quote need confirmation.
Compounded tirzepatide$133New-user injectable floorNew GLP-1 user starting amount; renewal and dose quote need confirmation.
Brand semaglutide$1498Ozempic brand starting priceAdvertised monthly brand-product floor.
Brand tirzepatide$1892Zepbound brand starting priceAdvertised monthly brand-product floor.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what NuuVim's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • LegitScript-certified and HIPAA-compliant
  • Explicitly discloses it does not manufacture its own compounded medications
  • Brand-name Ozempic and Zepbound available as a fallback option

The caveats

  • 50-state coverage is claimed elsewhere but not stated on NuuVim's own site
  • No postpartum, breastfeeding or PCOS-specific guidance found

New-user pricing is not a renewal promise

NuuVim advertises compounded semaglutide from $79 per month and compounded tirzepatide from $133 for new GLP-1 users. That qualification matters: the figures do not establish what an existing user or a returning patient pays. Ask how the company defines a new user and obtain the next refill amount for the dose prescribed to you. A low entry tier can be useful without being a dependable budget for all later treatment.

The current public offer does not resolve the complete dose ladder or ongoing renewal schedule. Request the quantity, supply duration, clinical charges, delivery cost, and any commitment together. If you are switching from another service, tell the clinician about the existing prescription rather than assuming the new-user amount applies. The price category and medical eligibility are separate questions. A clear quotation should explain both the first charge and what changes once the introductory eligibility no longer applies.

Branded options have very different advertised prices

NuuVim lists branded Ozempic from $1,498 per month and branded Zepbound from $1,892. Those are its advertised product floors, separate from the lower compounded offers. The brand names should not be substituted for one another, and their approved indications and labeling need to be discussed with a clinician. If a branded route is important, compare the actual prescription and complete charge with any manufacturer or insurance option you are eligible to use.

Earlier service information also describes oral options alongside injections. A shared ingredient name or similar price does not establish equivalence between an oral compounded preparation, an injection, and an approved branded product. Ask for a current form-specific quote rather than transferring an injectable starting amount to every route. The clinician should explain the proposed formulation and instructions. In particular, dose numbers for different routes should not be assumed interchangeable or used by a patient to calculate an independent switch.

The compounding disclosure is clear

NuuVim explicitly says it does not manufacture compounded medications and acknowledges that they have not been evaluated or approved by the FDA for safety, efficacy, or quality. That distinction should remain visible when considering the offer. It does not identify the actual pharmacy preparing your prescription. Request the dispensing partner's name, complete ingredients, concentration, quantity, storage requirements, and instructions before paying. A transparent general disclaimer and a clear prescription-specific supply arrangement answer different questions.

The company presents LegitScript certification and privacy-compliance claims. Without independent confirmation, treat those as company representations rather than a guarantee of current certification or clinical quality. State coverage also needs confirmation: a nationwide claim elsewhere has not been established on NuuVim's own public site. Ask whether the proposed medication and clinician can serve your location, including any travel or change of residence during treatment. Website access alone cannot establish that care is available.

Ask who supports you after the first purchase

The public information does not provide substantive pregnancy, breastfeeding, postpartum, or PCOS guidance. If relevant, request an individual discussion and ask how the service coordinates with your existing clinicians. General wellness positioning does not establish specialist experience. Also ask how questions reach the prescriber, whether follow-up appointments are available, and whether a changed prescription creates an extra charge. A low first payment has limited value if the continuing-care arrangement remains unclear.

NuuVim may interest someone exploring a low new-user compounded offer while also wanting to discuss branded alternatives. Its financial limitation is the unknown renewal amount, with much higher advertised branded prices belonging to a separate route. Obtain cancellation deadlines, refund conditions, and the complete first and next bills before choosing. The useful comparison keeps new-user eligibility, formulation, and ongoing care together, rather than allowing $79 or $133 to stand for every month and every form of treatment.

The bottom line for mothers

Best for: Mothers who want oral GLP-1 at the same price as the injection and are willing to confirm the refill-tier price before their first fill runs out.

Alternatives to NuuVim

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Compounded GLP-1s as an injection or an oral dissolving tablet, plus brand pens from $899 a month on a 3-month plan, in 49 states — but compounded prices appear only after the assessment and no cancellation policy is published.

    Visit Wellorithm
  • Four named pharmacies, a named prescribing partner and brand-name Wegovy, Zepbound and Ozempic alongside the compounded line — that is a fuller disclosure than most providers we review manage. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249, and the price attaches to the form rather than the molecule: the product page never says whether you are getting semaglutide or tirzepatide, and the terms confirm both are in scope. Two things deserve a mother's attention before she enrolls. The brand products are priced as a membership plus an undisclosed medication cost, and that membership is quoted at two different figures on one page, $99 beside Zepbound and Wegovy and $171 beside Ozempic. And the terms state that if a provider decides a different molecule suits you better, staying enrolled is itself your consent to the switch and the charges continue. It also discloses, unusually plainly, that people shown in its advertising may be actors or artificial intelligence rather than clinicians.

    Visit MEDGm

Providers like NuuVim

Keep comparing NuuVim

NuuVim, answered

How much does NuuVim cost as a new patient?
NuuVim advertises semaglutide from $79 a month and tirzepatide from $133 for new GLP-1 users. Confirm your dose and renewal amount before relying on either starting figure.
Does NuuVim serve all 50 states?
That claim is not repeated on NuuVim's own site, so treat it as unconfirmed and check with NuuVim directly.
Can I get brand-name Ozempic or Zepbound through NuuVim?
Yes, both are listed — Ozempic at $1,498/mo and Zepbound at $1,892/mo — but both sit well above what you'd pay through LillyDirect or NovoCare's own manufacturer self-pay channels.

Pricing, states and verification reflect NuuVim's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers